## **Core Concept**
The question revolves around the congenital infection likely to cause cerebral calcification and hydrocephalus in a newborn, particularly when the mother has a history of taking spiramycin but was not compliant with the therapy. This scenario points towards a parasitic infection, specifically toxoplasmosis, which is known to cause such neurological manifestations.

## **Why the Correct Answer is Right**
Toxoplasmosis, caused by the protozoan *Toxoplasma gondii*, is a well-known cause of congenital neurological abnormalities, including cerebral calcifications and hydrocephalus, especially if the infection occurs early in pregnancy. Spiramycin is a macrolide antibiotic used to treat toxoplasmosis in pregnant women, aiming to reduce the transmission of *T. gondii* from mother to fetus. Non-compliance with spiramycin therapy increases the risk of congenital toxoplasmosis, leading to potential severe outcomes like cerebral calcification and hydrocephalus in the newborn.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to any known agent associated with cerebral calcification and hydrocephalus in the context provided.
- **Option B:** Similarly, this option does not directly relate to a common cause of the described congenital neurological abnormalities.
- **Option C:** This option might seem plausible but does not directly link to the specific scenario of cerebral calcification and hydrocephalus associated with maternal non-compliance to spiramycin therapy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that congenital toxoplasmosis can be prevented or its severity reduced if pregnant women adhere to spiramycin therapy when prescribed due to serological evidence of *T. gondii* infection. The classic triad of congenital toxoplasmosis includes chorioretinitis, cerebral calcifications, and hydrocephalus. Early diagnosis and treatment are crucial.

## **Correct Answer:** . Toxoplasmosis